Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.
Kinaset Therapeutics has raised $103.0M in total funding. The most recent round was Series B. The last funding was announced in January 2026.
Kinaset Therapeutics's investors include RA Capital Management, Schroders Capital, Vivo Capital, EQT Life Sciences, 5AM Ventures.
Kinaset Therapeutics is headquartered in Boston, United States.
Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.
Kinaset Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kinaset Therapeutics — Funding & Investors." VCBacked, January 10, 2026, https://www.vcbacked.co/company/kinaset-therapeutics. Accessed July 19, 2026.
VCBacked. (2026). Kinaset Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/kinaset-therapeutics
{{cite web |title=Kinaset Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kinaset-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated